ISRCTN07452238CompletedNot Applicable
A study to determine the cardiovascular effects of different methods of administering the oxytocic drug Syntocino
Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)0 sites30 target enrollmentStarted: September 12, 2003Last updated:
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 30
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- Female
Inclusion Criteria
- •Women choosing spinal anaesthesia for elective Caesarean:
- •15 in control group receiving syntocinon 5 units intravenously (IV) as a bolus after delivery 15 in study group receiving syntocinon 5 units IV continuously over 5 min after delivery
Exclusion Criteria
- •Not provided at time of registration
Investigators
Similar Trials
Active, not recruiting
Phase 1
A trial investigating the cardiovascular safety of oral semaglutide in subjects with type 2 diabetesDiabetes Mellitus, Type 2EUCTR2015-003563-10-ROovo Nordisk A/S3,183
Active, not recruiting
Phase 1
A trial investigating the cardiovascular safety of oral semaglutide in subjects with type 2 diabetesDiabetes Mellitus, Type 2EUCTR2015-003563-10-ITOVO NORDISK. S.P.A.3,183
Active, not recruiting
Phase 1
A trial investigating the cardiovascular safety of oral semaglutide in subjects with type 2 diabetesDiabetes Mellitus, Type 2EUCTR2015-003563-10-GBovo Nordisk A/S3,183
Active, not recruiting
Phase 1
A trial investigating the cardiovascular safety of oral semaglutide in subjects with type 2 diabetesDiabetes Mellitus, Type 2EUCTR2015-003563-10-NLovo Nordisk A/S3,176
Active, not recruiting
Phase 1
A trial investigating the cardiovascular safety of oral semaglutide in subjects with type 2 diabetesMedDRA version: 19.0Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861Diabetes Mellitus, Type 2EUCTR2015-003563-10-ESovo Nordisk A/S3,176